What is the current valuation of the internet of-things-in-healthcare market in South Korea?

The market valuation was $1206.8 Million in 2024. Read More

What is the projected market size for the internet of-things-in-healthcare market by 2035?

The projected valuation for 2035 is $4000.4 Million. Read More

What is the expected CAGR for the internet of-things-in-healthcare market during the forecast period 2025 - 2035?

The expected CAGR is 11.51% during the forecast period. Read More

Which application segment has the highest projected valuation in the internet of-things-in-healthcare market?

The Patient Monitoring segment is projected to reach $1000.0 Million by 2035. Read More

What are the key components driving the internet of-things-in-healthcare market?

Key components include Devices, Software, and Services, with Services projected to reach $1400.4 Million. Read More

Which end-use segment is expected to dominate the internet of-things-in-healthcare market?

The Hospitals segment is anticipated to reach $2000.0 Million by 2035. Read More

What technology segments are contributing to the growth of the internet of-things-in-healthcare market?

Wearable Technology and Remote Patient Monitoring are significant contributors, with Remote Patient Monitoring projected at $1500.0 Million. Read More

Who are the leading players in the internet of-things-in-healthcare market?

Key players include Philips, GE Healthcare, Siemens Healthineers, and Samsung. Read More

What is the projected growth for the Medication Management segment in the internet of-things-in-healthcare market?

The Medication Management segment is expected to reach $800.0 Million by 2035. Read More

How does the internet of-things-in-healthcare market in South Korea compare to other regions?

While specific regional comparisons are not provided, the growth trajectory suggests a robust development in South Korea's market. Read More

South Korea Internet of Things in Healthcare Market

South Korea Internet of Things in Healthcare Market Research Report: Size, Share, Trend Analysis By Applications (Patient Monitoring, Medication Management, Telemedicine, Clinical Operations, Asset Management), By Component (Devices, Software, Services), By End Use (Hospitals, Diagnostics Centers, Home Care) and By Technology (Wearable Technology, Remote Patient Monitoring, Smart Medical Devices) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

11.51%

2024 Market Size

$ 1,206.8 Million

2035 Market Size

$ 4,000.4 Million

Healthcare ● Updated August 2026 Report ID: MRFR/HC/49826-HCR | Pages: 200 | Author: Rahul Gotadki

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Application (USD Million)
  1. 4.1.1 Patient Monitoring
  2. 4.1.2 Medication Management
  3. 4.1.3 Telemedicine
  4. 4.1.4 Clinical Operations
  5. 4.1.5 Asset Management
2. 4.2 Pharmaceutical, BY Component (USD Million)
  1. 4.2.1 Devices
  2. 4.2.2 Software
  3. 4.2.3 Services
3. 4.3 Pharmaceutical, BY End-Use (USD Million)
  1. 4.3.1 Hospitals
  2. 4.3.2 Diagnostics Centers
  3. 4.3.3 Home Care
4. 4.4 Pharmaceutical, BY Technology (USD Million)
  1. 4.4.1 Wearable Technology
  2. 4.4.2 Remote Patient Monitoring
  3. 4.4.3 Smart Medical Devices
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Philips (NL)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 GE Healthcare (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Siemens Healthineers (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Medtronic (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 IBM (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Cisco Systems (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Honeywell (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Samsung (KR)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Oracle (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
3. 6.3 SOUTH KOREA MARKET ANALYSIS BY COMPONENT
4. 6.4 SOUTH KOREA MARKET ANALYSIS BY END-USE
5. 6.5 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY
6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
12. 6.12 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
13. 6.13 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 PHARMACEUTICAL, BY COMPONENT, 2024 (% SHARE)
15. 6.15 PHARMACEUTICAL, BY COMPONENT, 2024 TO 2035 (USD Million)
16. 6.16 PHARMACEUTICAL, BY END-USE, 2024 (% SHARE)
17. 6.17 PHARMACEUTICAL, BY END-USE, 2024 TO 2035 (USD Million)
18. 6.18 PHARMACEUTICAL, BY TECHNOLOGY, 2024 (% SHARE)
19. 6.19 PHARMACEUTICAL, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY COMPONENT, 2025-2035 (USD Million)
  3. 7.2.3 BY END-USE, 2025-2035 (USD Million)
  4. 7.2.4 BY TECHNOLOGY, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

South Korea Pharmaceutical Market Segmentation

Pharmaceutical By Application (USD Million, 2025-2035)

Patient Monitoring
Medication Management
Telemedicine
Clinical Operations
Asset Management

Pharmaceutical By Component (USD Million, 2025-2035)

Devices
Software
Services

Pharmaceutical By End-Use (USD Million, 2025-2035)

Hospitals
Diagnostics Centers
Home Care

Pharmaceutical By Technology (USD Million, 2025-2035)

Wearable Technology
Remote Patient Monitoring
Smart South Korea Internet of Things in Healthcare Markets

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”